NEW YORK, June 4, 2002 (PRIMEZONE) -- Celestica's OPS (Operational-cashflow Per Share) for its most recent quarter of $1.19 and for its trailing 12-months of $8.15 are both record numbers for the company. Celestica also for the first time in its previous five-years, reported positive OPS for all four of its most recent quarters.
To view four-quarter, twenty-quarter, and five-year, OPS charts on Celestica (NYSE:CLS) and over 7,500 public companies, go to: http://www.stockdiagnostics.com
Celestica's OPS for its most recent 12-months ended March 31, 2002 was $8.15 as compared with ($1.83) for the 12-months ended March 31, 2001. Celestica's OPS for its most recent 12-months was the highest recorded for any 12-month period ending on March 31.
What is OPS?
OPS (TM) stands for "Operational-cashflow Per Share". It is derived from the line item "Cash Flow from Operations" which appears in a company's quarterly and annual Cash Flow Statements filed with the Securities & Exchange Commission. "OPS" is calculated by dividing a company's Cash Flow from Operations by the total number of shares outstanding. After conducting in-depth research on Operational-cashflow Per Share, StockDiagnostics.com determined that OPS can be used to measure the quality of a company's EPS and for monitoring its overall financial health. Cash Flow from Operations is a company's financial lifeblood and a sudden decrease in it can drain this lifeblood, causing an increase in debt, share dilution, share price erosion, and in the more extreme cases, bankruptcy.
For more information on OPS go to: http://www.stockdiagnostics.com/member/ops.htm
About StockDiagnostics.com
StockDiagnostics.com has designed and built a proprietary data refinery that automates the process of collecting, sorting, and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement and securities pricing variances or anomalies and to monitor changes in the performance of public companies.
For more information on StockDiagnostics.com.go to: http://www.stockdiagnostics.com/member/help.htm#a1
OPS, OPS Ratings, and The EPS Syndrome are all Trade Marks (TM) of StockDiagnostics.com.
-0-
CONATCT: Martin E. Janis & Company, Inc.
Beverly Jedynak, PR Contact
(312) 943-1100 ext. 12
b.jedynak-janispr@worldnet.att.net